Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
303
days
Are current Polish guidelines for prophylactic mastectomy sufficient?
Authors
Adam Stachowski; Cezary Cybulski; Jacek Gronwald; Tomasz Huzarski; Tadeusz Dębniak; Tomasz Byrski; Steven Narod; Rodney Scott; Jan LubińskiShow moreShow less
Affiliations
1. Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland; 2. Oncology and Chemotherapy Clinic, University Clinical Hospital no. 2 of the Pomeranian Medical University in Szczecin, Szczecin, Poland; 3. Women’s College Research Institute, Women’s College Hospital, University of Toronto, Toronto, Canada; 4. Centre for Cancer Detection and Therapy, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, Australia; 5. Division of Molecular Medicine, Pathology North, John Hunter Hospital, New Lambton, AustraliaShow moreShow less
108
days
Renal cell carcinoma risk among individuals heterozygous for fumarate hydratase variants: further insights into genotype-phenotype correlations
Authors
Trevor L. Hoffman; Sony Wirio; Vivek SethumadhavanShow moreShow less
Affiliations
1. Department of Genetics, Southern California Kaiser Permanente Medical Group, Pasadena, USA; 2. Bernard J. Tyson School of Medicine, Kaiser Permanente, Pasadena, USA; 3. Department of Pathology, Southern California Kaiser Permanente Medical Group, Pasadena, USAShow moreShow less
124
days
Breast cancer specialists’ experiences and attitudes towards mainstream genetic testing for patients with breast cancer
Authors
Kirsten Allan; Linda Cicciarelli; Catherine Beard; Geoffrey J. Lindeman; G. Bruce Mann; Paul A. James; Laura E. ForrestShow moreShow less
Affiliations
1. Department of Paediatrics, The University of Melbourne, Parkville, Australia; 2. Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Australia; 3. Department of Medicine, The University of Melbourne, Parkville, Australia; 4. The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; 5. Department of Surgery, The University of Melbourne, Parkville, Australia; 6. Sir Peter MacCallum, Department of Oncology, The University of Melbourne, Parkville, AustraliaShow moreShow less
186
days
Monitoring and treatment patterns of von Hippel-Lindau disease-associated central nervous system hemangioblastomas
Authors
Eric Jonasch; Yan Song; Jonathan Freimark; Manasi Mohan; James Signorovitch; Murali SundaramShow moreShow less
Affiliations
1. The University of Texas MD Anderson Cancer Center, Houston, USA; 2. Analysis Group, Inc., Boston, USA; 3. Merck & Co., Inc., Rahway, USAShow moreShow less
106
days
Impact of germline MMR gene variants on immune checkpoint inhibitors response in patients with MSI-H/dMMR digestive cancers: a retrospective cohort analysis
Authors
Antoine Dardenne; Camille Loisel; Anna Pellat; Alexandre Perrier; Julie Metras; Thomas Samaille; Yann Parc; Julie Leclerc; Romain Cohen; Thierry AndréShow moreShow less
Affiliations
1. Department of Medical Oncology, Saint-Antoine Hospital, AP-HP , Sorbonne University, Paris, France; 2. Department of Genetics, AP-HP, Pitié-Salpêtrière University Hospital, Sorbonne University, Paris, France; 3. Department of Digestive Surgery, AP-HP, Saint-Antoine Hospital, Sorbonne University, Paris, France; 4. Digestive Oncology Department, Gastroenterology, Digestive Endoscopy, Cochin Hospital, AP-HP Centre, Paris, France; 5. Faculty of Médecine, Paris Cité University, Paris, France; 6. Paris Cité University and Sorbonne Paris Nord University, INSERM, INRAe, Center for Research in Epidemiology and Statistics (CRESS), Hôtel Dieu Hospital, Paris, France; 7. Lille University, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France; 8. Molecular Oncogenetics Unit, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France; 9. Unité Mixte de Recherche Scientifique 938 and SIRIC CURAMUS, Centre de Recherche Saint-Antoine Hospital, Equipe Instabilité des Microsatellites et Cancer, Equipe Labellisée par la Ligue Nationale Contre le Cancer, Inserm, Paris, FranceShow moreShow less
60
days
Importance of genetic testing in childhood cancer survivors for hereditary cancer predisposition syndromes
Authors
Anja Urbas; Polona Ušaj; Boštjan Šeruga; Mateja Krajc; Simona Hotujec; Vida Stegel; Lorna Zadravec ZaletelShow moreShow less
Affiliations
1. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; 2. Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; 3. Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia; 4. Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia; 5. Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia; 6. Division of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, SloveniaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
